Purchases and Sales Made in Q1 2023 in Celyad Oncology Sa (CYAD)
This table provides information about the institutional ownership of Celyad Oncology Sa (CYAD) during Q1 2023. The information is specifically focused on institutions that hold shares of Celyad Oncology SA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Mar 29, 2024
Q1 2023
|
Kapitalo Investimentos Ltda
Sao Paulo, D5 |
BUY
|
- |
31.3KNew |
$15.7K - $74.2K
|
31.3K
$16.3K
|
|
|
May 15, 2023
Q1 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
11KNew |
$5.52K - $26.1K
|
11K
$5.74K
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-3.66K- 63.3% |
$1.83K - $8.68K
|
2.12K
$1.1K
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-13.5K- 45.39% |
$6.77K - $32.1K
|
16.3K
$8.47K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-18.2K- 99.45% |
$9.1K - $43.1K
|
100
$52
|